Publications

Sodium MRI with 3D-cones as a measure of tumour cellularity in high grade serous ovarian cancer.

Authors: SS Deen, F Riemer, MA McLean, AB Gill, JD Kaggie, JT Grist, R Crawford, J L...

E-pub date: 1 Aug 2019

Journal name: Eur J Radiol Open

Combination of mTOR inhibition and paclitaxel as a personalised strategy in the context of MYC-amplified high-grade serous ovarian cancer

Authors: FC Martins, D-L Couturier, I de Santiago, M Vias, D Sanders, A Piskorz, J H...

E-pub date: 1 Aug 2019

Journal name: ANNALS OF ONCOLOGY

A randomized double-blind placebo-controlled phase II trial comparing gemcitabine monotherapy to gemcitabine in combination with adavosertib in women with recurrent, platinum resistant epithelial ovarian cancer: A trial of the Princess Margaret, California, Chicago and Mayo Phase II Consortia.

Authors: S Lheureux, M Cabanero, MC Cristea, G Mantia-Smaldone, A Olawaiye, S Ellard...

E-pub date: 1 Aug 2019

Journal name: JOURNAL OF CLINICAL ONCOLOGY

ACTIVATION OF PIK3CA IN A MODEL OF ENDOMETRIOSIS MAY SHED LIGHT ON THE PATHOGENESIS OF OVARIAN CLEAR CELL ADENOCARCINOMA

Authors: CF Barbara, C King, M Jimenez-Linan, J Brenton, DS Charnock-Jones

E-pub date: 1 Aug 2019

Journal name: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Detection of ctDNA from dried blood spots after DNA size selection

Authors: K Heider, J Wan, J Hall, S Boyle, I Hudecova, D Gale, W Cooper, P Corrie, J...

E-pub date: 1 Aug 2019

Journal name:

Identification of ChIP-seq and RIME grade antibodies for Estrogen Receptor alpha.

Authors: S-E Glont, EK Papachristou, A Sawle, KA Holmes, JS Carroll, R Siersbaek

E-pub date: 1 Aug 2019

Journal name: PLoS One

The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver

Authors: J Carroll

E-pub date: 1 Aug 2019

Journal name:

PIONEER- Pre-operative wIndOw study of letrozole plus PR agonist megestrol acetate versus letrozole aloNE in post-menopausal patients with ER-positive breast cancer

Authors: SS Kumar, J Benson, S McIntosh, P King, G Dougall, A Kateb, A-L Vallier, L ...

E-pub date: 1 Aug 2019

Journal name:

Filters

Research Groups

Core Facilities

Start date

End date

Sodium MRI with 3D-cones as a measure of tumour cellularity in high grade serous ovarian cancer.

Combination of mTOR inhibition and paclitaxel as a personalised strategy in the context of MYC-amplified high-grade serous ovarian cancer

A randomized double-blind placebo-controlled phase II trial comparing gemcitabine monotherapy to gemcitabine in combination with adavosertib in women with recurrent, platinum resistant epithelial ovarian cancer: A trial of the Princess Margaret, California, Chicago and Mayo Phase II Consortia.

ACTIVATION OF PIK3CA IN A MODEL OF ENDOMETRIOSIS MAY SHED LIGHT ON THE PATHOGENESIS OF OVARIAN CLEAR CELL ADENOCARCINOMA

Detection of ctDNA from dried blood spots after DNA size selection

Identification of ChIP-seq and RIME grade antibodies for Estrogen Receptor alpha.

The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver

PIONEER- Pre-operative wIndOw study of letrozole plus PR agonist megestrol acetate versus letrozole aloNE in post-menopausal patients with ER-positive breast cancer

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Sodium MRI with 3D-cones as a measure of tumour cellularity in high grade serous ovarian cancer.

Combination of mTOR inhibition and paclitaxel as a personalised strategy in the context of MYC-amplified high-grade serous ovarian cancer

A randomized double-blind placebo-controlled phase II trial comparing gemcitabine monotherapy to gemcitabine in combination with adavosertib in women with recurrent, platinum resistant epithelial ovarian cancer: A trial of the Princess Margaret, California, Chicago and Mayo Phase II Consortia.

ACTIVATION OF PIK3CA IN A MODEL OF ENDOMETRIOSIS MAY SHED LIGHT ON THE PATHOGENESIS OF OVARIAN CLEAR CELL ADENOCARCINOMA

Detection of ctDNA from dried blood spots after DNA size selection

Identification of ChIP-seq and RIME grade antibodies for Estrogen Receptor alpha.

The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver

PIONEER- Pre-operative wIndOw study of letrozole plus PR agonist megestrol acetate versus letrozole aloNE in post-menopausal patients with ER-positive breast cancer